Advertisements
Business

Vaccine maker’s expansion bid for Covid jabs in Britain

Manufacturer of Oxford-AstraZeneca vaccine in talks with different builders about producing their Covid jabs in UK

A producer of the Oxford-AstraZeneca vaccine is in talks with different builders about producing their Covid jabs in Britain. 

CP Pharmaceuticals, owned by Indian drug-maker Wockhardt, has been producing Astra’s vaccine at its plant in Wrexham since final 12 months. 

Advertisements

Expansion plans: Wockhardt has told investors it has been 'exploring opportunities to tie up with various vaccine developers'

Expansion plans: Wockhardt has instructed traders it has been ‘exploring alternatives to tie up with numerous vaccine builders’

Last 12 months, the UK Government signed an 18-month contract to order manufacturing capability to make round 350million doses of Covid vaccines a 12 months in Wrexham. 

The contract was later prolonged to 24 months till August 2022. 

Advertisements

Now, in its annual report, Wockhardt has instructed traders it has been, ‘exploring alternatives to tie up with numerous vaccine builders for manufacturing and/or offering fill-finish services for Covid19 dosages’. 

Three vaccines are authorised for use in the UK – AstraZeneca, Moderna – which is made in Switzerland and the US – and Pfizer, largely made in Belgium.

Advertisement

Advertisements
Show More

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button